Pharmaceutical Business Review
Anonymous User | Login

Acura Submits Acurox Briefing Package To FDA

Published: 06-Aug-2009

Acurox, with proposed indication for the relief of moderate-to-severe pain

King Pharmaceuticals has submitted a briefing package to FDA addressing the issues raised in the Agency's June 30 Complete Response Letter (CRL), related to the New Drug Application (NDA) for Acurox (oxycodone HCl/niacin) Tablets.

Acura and King Pharmaceuticals Research and Development (King) are scheduled to meet with FDA in late third quarter of 2009, to discuss the CRL and the briefing package.

Acurox is an immediate release tablet with a proposed indication for the relief of moderate-to-severe pain. Acurox incorporates Acura's Aversion Technology and is intended to discourage product misuse and abuse.

Acura and King are developing Acurox and three additional opioid analgesic products, utilizing Aversion Technology.

Share

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Solutions4Science

Temperature Mapping and Validation Services ...

Exploristics

Innovative Analysis Solutions for Data Exploration, Pharmacogenetics, Biomarkers and Exploratory Sta...

NeuroProof

Screening Services for Pre-Clinical Development of Neuro-Pharmaceuticals and Safety Pharmacology ...

DASGIP

Parallel Bioreactor Systems for the Cultivation of Bacterial, Phototrophic, Animal and Human Cells ...

BioKinetic Europe

Phase I/II Contract Research Organisation ...

Toxikon Europe

CRO Providing Preclinical Safety Studies for the Life Science Community ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

Elan Corporation, plc

Elan Corporation, plc (Elan) is an Irish based biotechnology company, incepted in 1969. ...

Par Pharmaceutical Companies, Inc.

Par Pharmaceutical Companies, Inc. (Par Pharmaceutical) is a pharmaceutical company eng ...

Endo Pharmaceuticals Holdings Inc.

Endo Pharmaceuticals Holding Inc. (Endo) is a pharmaceutical company focused on the res ...

Purdue Pharma L.P.

Purdue Pharma L.P. (Purdue) is a privately held pharmaceutical company. It is principal ...

Pfizer Inc.

Pfizer Inc. (Pfizer) is a global research based pharmaceutical company principally focu ...

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address